BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perry SR, Xu W, Wirija A, Lim J, Yau MK, Stoermer MJ, Lucke AJ, Fairlie DP. Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist Discovery. J Chem Inf Model 2015;55:1181-91. [PMID: 26000704 DOI: 10.1021/acs.jcim.5b00087] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Jabeen A, Vijayram R, Ranganathan S. A two-stage computational approach to predict novel ligands for a chemosensory receptor. Curr Res Struct Biol 2020;2:213-21. [PMID: 34235481 DOI: 10.1016/j.crstbi.2020.10.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Jabeen A, Vijayram R, Ranganathan S. BIO-GATS: A Tool for Automated GPCR Template Selection Through a Biophysical Approach for Homology Modeling. Front Mol Biosci 2021;8:617176. [PMID: 33898512 DOI: 10.3389/fmolb.2021.617176] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Saqib U, Savai R, Liu D, Banerjee S, Baig MS. Drug repositioning as an effective therapy for protease-activated receptor 2 inhibition. J Cell Biochem 2019;120:1522-6. [PMID: 30370939 DOI: 10.1002/jcb.27334] [Reference Citation Analysis]
4 Kennedy AJ, Ballante F, Johansson JR, Milligan G, Sundström L, Nordqvist A, Carlsson J. Structural Characterization of Agonist Binding to Protease-Activated Receptor 2 through Mutagenesis and Computational Modeling. ACS Pharmacol Transl Sci 2018;1:119-33. [PMID: 32219208 DOI: 10.1021/acsptsci.8b00019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
5 Lim VJY, Du W, Chen YZ, Fan H. A benchmarking study on virtual ligand screening against homology models of human GPCRs. Proteins 2018;86:978-89. [DOI: 10.1002/prot.25533] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
6 Lim VJY, Du W, Chen YZ, Fan H. A benchmarking study on virtual ligand screening against homology models of human GPCRs.. [DOI: 10.1101/284075] [Reference Citation Analysis]
7 Readmond C, Wu C. Investigating detailed interactions between novel PAR1 antagonist F16357 and the receptor using docking and molecular dynamic simulations. Journal of Molecular Graphics and Modelling 2017;77:205-17. [DOI: 10.1016/j.jmgm.2017.08.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Suen J, Adams M, Lim J, Madala P, Xu W, Cotterell A, He Y, Yau M, Hooper J, Fairlie D. Mapping transmembrane residues of proteinase activated receptor 2 (PAR 2 ) that influence ligand-modulated calcium signaling. Pharmacological Research 2017;117:328-42. [DOI: 10.1016/j.phrs.2016.12.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
9 Saxena AK, Bhunia SS, Saxena M. Integration on Ligand and Structure Based Approaches in GPCRs. Topics in Medicinal Chemistry 2017. [DOI: 10.1007/7355_2016_24] [Reference Citation Analysis]
10 Yau MK, Liu L, Suen JY, Lim J, Lohman RJ, Jiang Y, Cotterell AJ, Barry GD, Mak JY, Vesey DA, Reid RC, Fairlie DP. PAR2 Modulators Derived from GB88. ACS Med Chem Lett 2016;7:1179-84. [PMID: 27994760 DOI: 10.1021/acsmedchemlett.6b00306] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
11 Cho N, Seo S, Kim D, Shin J, Ju J, Seong J, Seo SH, Lee I, Lee K, Kim YK, No KT, Pae AN. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist. J Comput Aided Mol Des 2016;30:625-37. [DOI: 10.1007/s10822-016-9937-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Yau M, Liu L, Lim J, Lohman R, Cotterell AJ, Suen JY, Vesey DA, Reid RC, Fairlie DP. Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity. Bioorganic & Medicinal Chemistry Letters 2016;26:986-91. [DOI: 10.1016/j.bmcl.2015.12.048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
13 Kumari P, Ghosh E, Shukla AK. Emerging Approaches to GPCR Ligand Screening for Drug Discovery. Trends in Molecular Medicine 2015;21:687-701. [DOI: 10.1016/j.molmed.2015.09.002] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
14 Xu W, Lim J, Goh C, Suen JY, Jiang Y, Yau M, Wu K, Liu L, Fairlie DP. Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2. J Chem Inf Model 2015;55:2079-84. [DOI: 10.1021/acs.jcim.5b00500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]